Five Prime Therapeutics Upgraded by Wedbush on 6/22/2020. In a note
to investors, the firm issued a new rating of Outperform. The analysts
previously had rating of Neutral.
https://stockmarketdaily.co/2020/06/22/five-prime-therapeutics-nasdaqfprx-upgraded-by-wedbush-to-outperform/
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.